<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (NOS) activity is increased during <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>NOS inactivation reduces <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced cerebral injuries, but little is known about its role in blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) disruption and <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> formation during <z:hpo ids='HP_0001297'>stroke</z:hpo> in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we investigated the role of NOS inhibition in progression of <z:hpo ids='HP_0000969'>edema</z:hpo> formation and <z:chebi fb="2" ids="33602">BBB</z:chebi> disruptions provoked by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injuries in <z:hpo ids='HP_0011009'>acute</z:hpo> hypertensive rats </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Rats were made acutely hypertensive by <z:hpo ids='HP_0001680'>aortic coarctation</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>After 7 days, the rats were randomly selected for the recording of carotid artery pressure, or regional cerebral blood flow (rCBF) using laser Doppler </plain></SENT>
<SENT sid="5" pm="."><plain>Ishcemia induced by 60-min middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), followed by 12-h reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>A single i.p. dose of L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> (1 mg/kg) was injected before MCAO </plain></SENT>
<SENT sid="7" pm="."><plain>After evaluation of neurological disabilities, rats were slaughtered under deep anesthesia to assess <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> volume, <z:hpo ids='HP_0000969'>edema</z:hpo>, or <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: A 75-85% reduction in rCBF was occurred during MCAO which returned to pre-occluded levels during reperfusion </plain></SENT>
<SENT sid="9" pm="."><plain>Profound neurological disabilities were evidenced after MCAO alongside with severe <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarctions</z:e> (628 ± 98 mm3), considerable <z:hpo ids='HP_0000969'>edema</z:hpo> (4.05 ± 0.52%) and extensive <z:chebi fb="2" ids="33602">BBB</z:chebi> disruptions (Evans blue extravasation, 8.46 ± 2.03 mug/g) </plain></SENT>
<SENT sid="10" pm="."><plain>L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> drastically improved neurological disabilities, diminished <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> (264 ± 46 mm3), reduced <z:hpo ids='HP_0000969'>edema</z:hpo> (1.49 ± 0.47%) and <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption (2.93 ± 0.66 mug/g) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: The harmful actions of NOS activity on cerebral microvascular integrity are intensified by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injuries during <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>NOS inactivation by L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> preserved this integrity and diminished <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> </plain></SENT>
</text></document>